Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique
ContributorsDistler, Joerg H W; Jordan, Suzana; Airo, Paolo; Alegre-Sancho, Juan Jose; Allanore, Yannick; Balbir Gurman, Alexandra; Caporali, Roberto; Caramaschi, Paola; Carreira, Patricia E; Chizzolini, Carlo; Cutolo, Maurizio; Tuncay Duruöz, Mehmet; Farge-Bancel, Dominique; Hesselstrand, Roger; Iannone, Florenzo; De Keyser, Filip; Kucharz, Eugene J; Launay, David; García de la Peña Lefebvre, Paloma; Lukacova, Olga; Marasini, Bianca; Martinovic, Duska; Marques Neto, João Francisco; Radic, Mislav; Rednic, Simona; Riemekasten, Gabriela; Rovensky, Josef; Seidel, Matthias F; Senel, Soner; Smith, Vanessa; Sunderkötter, Cord; Ton, Evelien; van Laar, Jacob M; Matucci-Cerinic, Marco; Müller Ladner, Ulf; Distler, Oliver
Published inClinical and Experimental Rheumatology, vol. 29, no. 2 Suppl 65, p. S40-45
Publication date2011
Abstract
Keywords
- Anti-Inflammatory Agents/administration & dosage/adverse effects
- Arthritis/drug therapy/etiology/immunology/pathology
- Consensus
- Delphi Technique
- Disease Progression
- Fibrosis
- Humans
- Immunologic Factors/administration & dosage/adverse effects
- Inflammation
- Off-Label Use
- Scleroderma, Systemic/complications/drug therapy/pathology
- Treatment Outcome
- Tumor Necrosis Factor-alpha/antagonists & inhibitors
Affiliation entities
Research groups
Citation (ISO format)
DISTLER, Joerg H W et al. Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique. In: Clinical and Experimental Rheumatology, 2011, vol. 29, n° 2 Suppl 65, p. S40–45.
Main files (1)
Article (Published version)
Identifiers
- PID : unige:43462
- PMID : 21586217
Journal ISSN0392-856X
